PVAX was prepared by encapsulating BRD4 inhibitor (JQ-1) and indocyanine green (ICG) co-loaded tumor cells through a hydrogel matrix, which could simultaneously elicit antitumor immunity and block the PD-L1/PD-1 checkpoint to prevent tumor recurrence and metastasis. The gene discussed is CD274; the disease is neoplasm.